What is clinical trial design?

Clinical trial design is the process of planning and structuring a study to ensure the quality of clinical data. It includes protocol development, population selection, site choice, a monitoring plan, a data-management strategy, and statistical analysis. This is the key preparatory phase for any medical-device clinical-trial project.

Objective and scope of the clinical-trial project

The study must define its objective clearly—for example, confirming diagnostic performance, comparing the device with alternative solutions, or assessing new functionalities. The scope should cover standard conditions of use and potential boundary scenarios, taking into account the influence of clinical practice on outcomes.

Designing population selection and eligibility criteria

Precisely defined inclusion and exclusion criteria are critical for representative results. Demographics, health status, comorbidities, and treatment history must all be considered. An effective recruitment strategy increases the chances of finishing the trial on schedule.

Designing investigational-site selection

Choosing suitable sites should be based on their experience, access to the target patient group, and technical resources. The selection process is supported by an assessment of site qualification and a feasibility analysis in the specific clinical setting.

Incorporating device characteristics into study design

Every design should include a device description, its MDR classification, intended clinical use, and known technological limitations. Pre-clinical data and previous performance results directly influence study assumptions.

Study description as part of clinical-trial design

The description must provide the scientific rationale, randomisation details, blinding (if applicable), sample size (per power analysis), and timeline. Plans for handling protocol deviations and unforeseen situations should also be included.

Designing the monitoring plan and data-management system

The project must incorporate a clear clinical-trial monitoring plan and a data-management strategy—both for eCRF systems and paper records. Consistency with the requirements in clinical-trial data management is essential, including quality control and auditability.

Designing risk assessment and the statistical-analysis plan

The design should identify risks, describe mitigation measures, and outline adverse-event reporting. The statistical section must contain the data-analysis plan, rules for handling missing data, and interim-analysis procedures. Further details are available in statistical analysis of clinical trials.

Ethical aspects of clinical-trial design

Every clinical-trial design must comply with GCP and the Declaration of Helsinki. The informed-consent process must be transparent, voluntary, and comprehensible. Detailed information belongs in the investigator brochure and participant information sheets.

Documentation and submission within study design

The submission package for competent authorities must include the full study plan, investigator brochure, informed-consent forms, and participant-insurance documentation. All documents must meet notified-body and regulatory requirements, in line with clinical-trial reporting procedures.

How Pure Clinical supports clinical-trial design

Pure Clinical experts assist medical-device sponsors at every design stage. With experience in MDR, ISO 14155:2022, and GCP, we deliver effective documentation and prepare projects that satisfy regulators.

  • defining study objectives and protocol structure,
  • creating the investigator brochure and consent forms,
  • feasibility assessment and site qualification,
  • establishing recruitment criteria and methodology,
  • designing data-management and monitoring systems,
  • support in compiling the submission dossier.

FAQ

How does the design of a clinical investigation begin?

The design process starts with defining the objective of the study, the target population, and the recruitment strategy. A key document is the clinical investigation protocol, which outlines the study methodology, endpoints, and the statistical analysis plan.

What should a well-prepared clinical investigation protocol include?

The protocol should include a scientific rationale, a description of the device, inclusion and exclusion criteria for participants, a study timeline, detailed procedures, and the statistical analysis plan.

Who is responsible for designing a clinical investigation?

The study sponsor is responsible for the design, often in collaboration with an external organization (e.g. a Contract Research Organization, CRO), which supports tasks such as documentation preparation, feasibility assessment, and site selection.

What input data are needed to design a clinical investigation?

The design requires preclinical data, device classification, existing clinical evidence (if available), a description of the target population, and a defined risk profile along with regulatory requirements.

What are the most common mistakes in clinical investigation design?

Common issues include vague study objectives, underestimated sample size, unclear eligibility criteria, and non-compliance with MDR, Good Clinical Practice (GCP), or ISO 14155 standards.

Does the design process differ depending on the device classification?

Yes, the design of studies involving Class III devices or implants is more complex and requires more extensive documentation, a broader risk analysis, and typically involves a greater number of investigational sites.